Emerging resistance to antibiotics: Impact on respiratory infections in the outpatient setting

被引:19
作者
Green, M
Wald, ER
机构
[1] UNIV PITTSBURGH, SCH MED, DEPT SURG, PITTSBURGH, PA 15260 USA
[2] UNIV PITTSBURGH, SCH MED, DEPT OTOLARYNGOL, PITTSBURGH, PA 15260 USA
[3] UNIV PITTSBURGH, SCH MED, DEPT PEDIAT, PITTSBURGH, PA 15261 USA
关键词
D O I
10.1016/S1081-1206(10)63250-4
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Objective: To review the major mechanisms of antibiotic resistance and provide an overview of currently available oral antibiotics. This article discusses the impact of antibiotic resistance on respiratory infections (eg, otitis media, sinusitis, and pneumonia) encountered in the outpatient setting and appropriate mana strategies for these infections are proposed. Data Sources: A Medline search was performed to identify recent references from the English language pertinent to this topic. Proposed management schemes for infections due to antibiotic-resistant bacteria were derived from current literature as well as the opinion of the authors. Results: Currently available oral antibiotics including penicillins, cephalosporins, macrolides, trimethroprim/sulfamethoxazole, and clindamycin continue to provide effective therapeutic options despite the increasing importance of antibiotic resistance in bacteria causing respiratory tract infections in the outpatient setting. The effectiveness of a given agent may no longer be assured, leading to the need for development of updated management strategies for patients experiencing treatment failure with antibiotics. Diagnostic strategies (ie, tympanocentesis) and novel treatment algorithms (eg, use of amoxicillin in combination with amoxicillin/clavulanate) for patients experiencing clinical failures potentially due to antibiotic-resistant bacteria are proposed. Conclusions: The increasing prevalence of antibiotic resistant bacteria (especially penicillin-resistant Streptococcus pneumoniae) is leading to new approaches to the management of common respiratory infections in the outpatient setting. Additional experience and careful clinical trials are necessary to identify optimal management strategies for these infections.
引用
收藏
页码:167 / 173
页数:7
相关论文
共 21 条
[1]  
BARNETT ED, 1995, PEDIATR CLIN N AM, V42, P509
[2]   Consensus: Management of infections in children caused by Streptococcus pneumoniae with decreased susceptibility to penicillin [J].
Bradley, JS ;
Kaplan, SL ;
Klugman, KP ;
Leggiadro, RJ .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1995, 14 (12) :1037-1041
[3]   TRIMETHOPRIM-SULFAMETHOXAZOLE [J].
COCKERILL, FR ;
EDSON, RS .
MAYO CLINIC PROCEEDINGS, 1991, 66 (12) :1260-1269
[4]   BACTERIAL-RESISTANCE MECHANISMS AS THERAPEUTIC TARGETS [J].
COLEMAN, K ;
ATHALYE, M ;
CLANCEY, A ;
DAVISON, M ;
PAYNE, DJ ;
PERRY, CR ;
CHOPRA, I .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (06) :1091-1116
[5]   INACTIVATION OF ANTIBIOTICS AND THE DISSEMINATION OF RESISTANCE GENES [J].
DAVIES, J .
SCIENCE, 1994, 264 (5157) :375-382
[6]  
FRIEDLAND IR, 1994, NEW ENGL J MED, V331, P377, DOI 10.1056/NEJM199408113310607
[7]   CEPHALOSPORIN ANTIMICROBIAL AGENTS AND RELATED-COMPOUNDS [J].
GUSTAFERRO, CA ;
STECKELBERG, JM .
MAYO CLINIC PROCEEDINGS, 1991, 66 (10) :1064-1073
[8]   ANTIMICROBIAL RESISTANCE AMONG RESPIRATORY ISOLATES OF HAEMOPHILUS-INFLUENZAE, MORAXELLA-CATARRHALIS, AND STREPTOCOCCUS-PNEUMONIAE IN THE UNITED-STATES [J].
JORGENSEN, JH ;
DOERN, GV ;
MAHER, LA ;
HOWELL, AW ;
REDDING, JS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (11) :2075-2080
[9]  
LEVINE LR, 1985, PEDIATR INFECT DIS J, V4, P358, DOI 10.1097/00006454-198507000-00005
[10]   ACTIVE EFFLUX MECHANISMS FOR ANTIMICROBIAL RESISTANCE [J].
LEVY, SB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (04) :695-703